Search - tctmd.com

Displaying 981 - 1000 of 1355

Sort: Relevancy | Date

Presentation TVT 2015

New Transapical Access Closure Devices

Presenter: Mani Arsalan, MD

June 05, 2015

Presentation TVT 2015

Case Presentation: Mild-Moderate Paravalvular Regurgitation During/After TAVR

Presenter: Antonio Colombo, A. Pieter Kappetein, Torsten P. Vahl

June 05, 2015

Presentation TVT 2015

SAPIEN 3 Sizing Considerations: Oversizing, Undersizing, or Volume Reduction

Presenter: John G. Webb

June 05, 2015

Presentation TVT 2015

Prevention and Management of Conduction Disturbances and Arrhythmias (AF) After TAVR

Presenter: Tamim Nazif

June 05, 2015

Presentation TVT 2015

New Transfemoral Access Closure Devices

Presenter: Eberhard Grube

June 05, 2015

Presentation TVT 2015

Thoughtful Commentary: AS and the Failing Bioprosthetic Mitral Valve

Presenter: Antonio Colombo, A. Pieter Kappetein, Neil E. Moat

June 05, 2015

Presentation TVT 2015

CT Valve Sizing Algorithms for the CoreValve Self-Expanding Valve: Lessons From the US CoreValve Experience

Presenter: Jeffrey J. Popma

June 05, 2015

Presentation TVT 2015

Incidence and Prognostic Impact of Conduction Disturbances and Arrhythmias (AF) After TAVR

Presenter: Josep Rodés-Cabau

June 05, 2015

Presentation TVT 2015

Case Presentation: AS and the Failing Bioprosthetic Mitral Valve

Presenter: Antonio Colombo, A. Pieter Kappetein, Mathew Williams

June 05, 2015

Presentation TVT 2015

Technology Overview and Perspectives From the DEFLECT III Randomized Trial

Presenter: Joachim Schofer

June 05, 2015

Presentation TVT 2015

CT Valve Sizing Algorithms for the SAPIEN Balloon-Expandable Valve: Methodology and Guidelines

Presenter: Jonathon A. Leipsic

June 05, 2015

Presentation TVT 2015

Thoughtful Commentary: High Risk for Coronary Occlusion and TAVR

Presenter: Antonio Colombo, A. Pieter Kappetein, Raj Makkar

June 05, 2015

Presentation TVT 2015

Early and Late Bleeding After TAVR: Poorly Understood and Associated With Increased Mortality

Presenter: Philippe Genereux

June 05, 2015

Presentation TVT 2015

Case Presentation: High Risk for Coronary Occlusion and TAVR

Presenter: Antonio Colombo, A. Pieter Kappetein, Torsten P. Vahl

June 05, 2015

Presentation TVT 2015

The Concept and Application of Balloon Sizing to Guide Valve Sizing and Selection

Presenter: Jonathon A. Leipsic, Jeffrey J. Popma, Helene Eltchaninoff

June 05, 2015

Presentation TVT 2015

Updates From the US FDAApproved Sentinel TAVR Safety and Efficacy Study

Presenter: Susheel K. Kodali

June 05, 2015

Presentation TVT 2015

The Concept and Application of Cover Index to Guide Valve Sizing and Selection

Presenter: Jonathon A. Leipsic, Jeffrey J. Popma, Thierry Lefevre

June 05, 2015

Presentation TVT 2015

Avoiding and Managing Nontransfemoral Access Site Complications

Presenter: Vinayak Bapat

June 05, 2015

Presentation TVT 2015

Thoughtful Commentary: High Risk for Pacemaker With LV Dysfunction and TAVR

Presenter: Antonio Colombo, A. Pieter Kappetein, Tamim Nazif

June 05, 2015

Presentation TVT 2015

Avoiding and Managing Transfemoral Vascular Complications

Presenter: Augusto D. Pichard

June 05, 2015

Advertisement

New Transapical Access Closure Devices

Case Presentation: Mild-Moderate Paravalvular Regurgitation During/After TAVR

SAPIEN 3 Sizing Considerations: Oversizing, Undersizing, or Volume Reduction

Prevention and Management of Conduction Disturbances and Arrhythmias (AF) After TAVR

New Transfemoral Access Closure Devices

Thoughtful Commentary: AS and the Failing Bioprosthetic Mitral Valve

CT Valve Sizing Algorithms for the CoreValve Self-Expanding Valve: Lessons From the US CoreValve Experience

Incidence and Prognostic Impact of Conduction Disturbances and Arrhythmias (AF) After TAVR

Case Presentation: AS and the Failing Bioprosthetic Mitral Valve

Technology Overview and Perspectives From the DEFLECT III Randomized Trial

CT Valve Sizing Algorithms for the SAPIEN Balloon-Expandable Valve: Methodology and Guidelines

Thoughtful Commentary: High Risk for Coronary Occlusion and TAVR

Early and Late Bleeding After TAVR: Poorly Understood and Associated With Increased Mortality

Case Presentation: High Risk for Coronary Occlusion and TAVR

The Concept and Application of Balloon Sizing to Guide Valve Sizing and Selection

Updates From the US FDAApproved Sentinel TAVR Safety and Efficacy Study

The Concept and Application of Cover Index to Guide Valve Sizing and Selection

Avoiding and Managing Nontransfemoral Access Site Complications

Thoughtful Commentary: High Risk for Pacemaker With LV Dysfunction and TAVR

Avoiding and Managing Transfemoral Vascular Complications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content